Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M O'Connor

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Genes and Immunity|July 4, 2014
Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expressionP W Wright, H Li, A Huehn, et al.
Biosensors & Bioelectronics|February 13, 2002
Characterisation of an antibody coated microcantilever as a potential immuno-based biosensorC Grogan, R Raiteri, G M O'Connor, et al.
HLA|June 27, 2018
Activating KIR Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Hematopoietic Stem Cell TransplantationS L Heatley, C G Mullighan, K Doherty, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Genes and Immunity|July 4, 2014
Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expressionP W Wright, H Li, A Huehn, et al.
Biosensors & Bioelectronics|February 13, 2002
Characterisation of an antibody coated microcantilever as a potential immuno-based biosensorC Grogan, R Raiteri, G M O'Connor, et al.
HLA|June 27, 2018
Activating KIR Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Hematopoietic Stem Cell TransplantationS L Heatley, C G Mullighan, K Doherty, et al.
Pageof 2